Variant report

Variant	esv3400389
Chromosome Location	chr1:165325128-165326976
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:20)
CpG islands
(count:610)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:20 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD1	chr1:165325602-165325802	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD1	chr1:165326228-165326405	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTBP2	chr1:165322985-165326544	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr1:165326400-165326550	WERI-Rb-1	eye:	n/a	chr1:165326504-165326511
5	CTCF	chr1:165325484-165325485	Fibrobl	skin:	n/a	n/a
6	CTCF	chr1:165325380-165325530	AG09319	gingival:	n/a	n/a
7	CTCF	chr1:165325260-165325410	AG04449	skin:	n/a	chr1:165325353-165325366
8	CTCF	chr1:165325447-165325480	Fibrobl	skin:	n/a	n/a
9	GABPA	chr1:165326136-165326460	H1-hESC	embryonic stem cell:	n/a	n/a
10	NRF1	chr1:165325614-165325691	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr1:165325775-165325866	H1-hESC	embryonic stem cell:	n/a	n/a
12	RAD21	chr1:165326205-165326655	H1-hESC	embryonic stem cell:	n/a	chr1:165326502-165326511
13	RAD21	chr1:165325478-165325587	H1-hESC	embryonic stem cell:	n/a	n/a
14	REST	chr1:165326042-165326454	H1-hESC	embryonic stem cell:	n/a	n/a
15	REST	chr1:165326033-165326444	H1-hESC	embryonic stem cell:	n/a	n/a
16	SIN3A	chr1:165325476-165326555	H1-hESC	embryonic stem cell:	n/a	n/a
17	SUZ12	chr1:165320994-165326901	NT2-D1	testis:	n/a	n/a
18	SUZ12	chr1:165321480-165326928	H1-hESC	embryonic stem cell:	n/a	n/a
19	TBP	chr1:165325637-165325843	H1-hESC	embryonic stem cell:	n/a	n/a
20	ZNF143	chr1:165325687-165325868	H1-hESC	embryonic stem cell:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:165326269-165326319	MCF-7	breast:	n/a
2	chr1:165326327-165326377	MCF-7	breast:	n/a
3	chr1:165325673-165325723	GM12891	blood:	n/a
4	chr1:165325169-165325219	SKMC	muscle:	n/a
5	chr1:165325553-165325603	PANC-1	pancreas:	n/a
6	chr1:165325136-165325186	HMEC	breast:	n/a
7	chr1:165325231-165325281	SK-N-SH	brain:	n/a
8	chr1:165326345-165326395	HRE	kidney:	n/a
9	chr1:165325136-165325186	NHBE	bronchial:	n/a
10	chr1:165325553-165325603	MCF10A-Er-Src	breast:	n/a
11	chr1:165325673-165325723	H1-hESC	embryonic stem cell:	embryo
12	chr1:165325553-165325603	HCT-116	colon:	n/a
13	chr1:165325498-165325548	CMK	blood:	n/a
14	chr1:165325553-165325603	Hepatocyte	liver:	n/a
15	chr1:165326327-165326377	NB4	blood:	n/a
16	chr1:165326269-165326319	GM12891	blood:	n/a
17	chr1:165326345-165326395	AG04449	skin:	fetal
18	chr1:165325673-165325723	U87	brain:	n/a
19	chr1:165326269-165326319	LNCaP	prostate:	n/a
20	chr1:165326345-165326395	MCF10A-Er-Src	breast:	n/a
21	chr1:165326269-165326319	NHBE	bronchial:	n/a
22	chr1:165325673-165325723	NH-A	brain:	n/a
23	chr1:165325231-165325281	HRE	kidney:	n/a
24	chr1:165326345-165326395	ECC-1	luminal epithelium:	n/a
25	chr1:165325553-165325603	NHDF-neo	bronchial:	n/a
26	chr1:165325169-165325219	Caco-2	colon:	n/a
27	chr1:165326269-165326319	AG09319	gingival:	n/a
28	chr1:165325833-165325883	HRPEpiC	eye:	n/a
29	chr1:165326269-165326319	ovcar-3	ovarian:	n/a
30	chr1:165325553-165325603	MCF-7	breast:	n/a
31	chr1:165326345-165326395	HCPEpiC	choroid plexus:	n/a
32	chr1:165325169-165325219	HRE	kidney:	n/a
33	chr1:165325231-165325281	K562	blood:	n/a
34	chr1:165325231-165325281	HCPEpiC	choroid plexus:	n/a
35	chr1:165326327-165326377	AG04449	skin:	fetal
36	chr1:165326269-165326319	U87	brain:	n/a
37	chr1:165326269-165326319	HEK293	kidney:	embryo
38	chr1:165325169-165325219	AG10803	skin:	n/a
39	chr1:165325169-165325219	SK-N-SH	brain:	n/a
40	chr1:165325673-165325723	NT2-D1	testis:	n/a
41	chr1:165325136-165325186	Hela-S3	cervix:	n/a
42	chr1:165325673-165325723	K562	blood:	n/a
43	chr1:165325553-165325603	NH-A	brain:	n/a
44	chr1:165325553-165325603	GM19239	blood:	n/a
45	chr1:165326269-165326319	GM19239	blood:	n/a
46	chr1:165326269-165326319	AoSMC	blood vessel:	n/a
47	chr1:165326327-165326377	Jurkat	blood:	n/a
48	chr1:165325498-165325548	AoSMC	blood vessel:	n/a
49	chr1:165326269-165326319	HRCEpiC	kidney:	n/a
50	chr1:165325498-165325548	AG04449	skin:	fetal

No data

Variant related genes	Relation type
LMX1A	TF binding region
LMX1A	CpG island

Extended variants
information (count: 72 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:72 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113381981	chr1:165325128-165325129	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs367968081	chr1:165325136-165325137	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs534875048	chr1:165325150-165325151	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs548571983	chr1:165325153-165325154	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs551928631	chr1:165325176-165325177	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs571781609	chr1:165325177-165325178	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
7	rs79925047	chr1:165325227-165325228	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs557277221	chr1:165325253-165325254	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs190171605	chr1:165325263-165325264	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs565499213	chr1:165325279-165325280	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs569717205	chr1:165325318-165325319	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs536264651	chr1:165325382-165325383	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs72687734	chr1:165325391-165325392	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs573266829	chr1:165325414-165325415	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs545208752	chr1:165325436-165325437	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs565082904	chr1:165325474-165325475	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs6665237	chr1:165325493-165325494	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs112895630	chr1:165325505-165325506	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs561174809	chr1:165325522-165325523	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs11802022	chr1:165325563-165325564	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs529678431	chr1:165325582-165325583	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs546638050	chr1:165325594-165325595	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs559919317	chr1:165325624-165325625	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs78807787	chr1:165325682-165325683	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs552026234	chr1:165325695-165325696	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs374158247	chr1:165325706-165325707	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs183417141	chr1:165325712-165325713	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs77128138	chr1:165325721-165325722	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs6689874	chr1:165325741-165325742	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs567641448	chr1:165325771-165325772	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs187905560	chr1:165325773-165325774	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs552934937	chr1:165325784-165325785	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs573199114	chr1:165325786-165325787	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs539122461	chr1:165325800-165325801	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs6665572	chr1:165325827-165325828	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs535565771	chr1:165325849-165325850	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs575357069	chr1:165325858-165325859	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs544432323	chr1:165325917-165325918	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs554872566	chr1:165325938-165325939	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs574760020	chr1:165325956-165325957	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs540566502	chr1:165325990-165325991	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs560084182	chr1:165326016-165326017	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs532056176	chr1:165326040-165326041	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs545835024	chr1:165326057-165326058	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs562459422	chr1:165326169-165326170	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs557585340	chr1:165326191-165326192	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs73019197	chr1:165326206-165326207	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs112450854	chr1:165326258-165326259	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs536700926	chr1:165326272-165326273	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs553345388	chr1:165326316-165326317	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	16750200	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Lung cancer	18438408	CNVD
Rett syndrome	21593744	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	17899364	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Type 2 diabetes	19141583	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	21611746	CNVD
Neuroblastoma	18923191	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	19287148	CNVD
Glomerulonephritis	19341492	CNVD
Systemic lupus erythematosus	18559452	CNVD
Systemic autoimmune disease	17597778	CNVD
Glomerulonephritis	17008540	CNVD
Glomerulonephritis	16482158	CNVD
Soft tissue tumor	16732325	CNVD
Cancer	17060936	CNVD
Lung cancer	16740712	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20409316	CNVD
Mental retardation	17847001	CNVD
Idiopathic thrombocytopenic purpura	17827395	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:202 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:165321200-165326400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
2	chr1:165321400-165326600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
3	chr1:165321600-165325200	Bivalent Enhancer	Fetal Stomach	stomach
4	chr1:165321600-165325400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
5	chr1:165321600-165326000	Enhancers	Pancreas	Pancrea
6	chr1:165322800-165326400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr1:165323200-165325400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
8	chr1:165323200-165325600	Bivalent Enhancer	Left Ventricle	heart
9	chr1:165323200-165326000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr1:165323400-165325200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr1:165323400-165326000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr1:165323400-165326200	Bivalent Enhancer	Fetal Brain Male	brain
13	chr1:165323400-165326400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
14	chr1:165323600-165326600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
15	chr1:165323800-165326400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
16	chr1:165324000-165325200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
17	chr1:165324000-165325200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr1:165324000-165325200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr1:165324000-165325600	Bivalent Enhancer	Fetal Heart	heart
20	chr1:165324000-165325800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
21	chr1:165324200-165325400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr1:165324200-165325600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
23	chr1:165324200-165325600	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
24	chr1:165324200-165325600	Bivalent Enhancer	Spleen	Spleen
25	chr1:165324200-165326000	Bivalent Enhancer	Placenta	Placenta
26	chr1:165324200-165326400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr1:165324400-165325400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
28	chr1:165324400-165325400	Bivalent Enhancer	Ovary	ovary
29	chr1:165324400-165325800	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr1:165324600-165325200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr1:165324600-165325200	Bivalent Enhancer	Esophagus	oesophagus
32	chr1:165324600-165325200	Enhancers	Right Atrium	heart
33	chr1:165324600-165325400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
34	chr1:165324600-165325400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
35	chr1:165324600-165325600	Bivalent Enhancer	HMEC	breast
36	chr1:165324600-165325800	Bivalent Enhancer	Lung	lung
37	chr1:165324600-165326000	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
38	chr1:165324600-165326000	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
39	chr1:165324600-165326200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr1:165324600-165326200	Flanking Bivalent TSS/Enh	Right Ventricle	heart
41	chr1:165324600-165326400	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
42	chr1:165324800-165325200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
43	chr1:165324800-165325200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr1:165324800-165325200	Bivalent Enhancer	Brain Hippocampus Middle	brain
45	chr1:165324800-165325200	Flanking Bivalent TSS/Enh	Colon Smooth Muscle	Colon
46	chr1:165324800-165325400	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr1:165324800-165325400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr1:165324800-165325400	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
49	chr1:165324800-165326000	Bivalent/Poised TSS	Fetal Intestine Small	intestine
50	chr1:165325000-165325200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links